Dr Annaliesa Anderson | Vice President and CSO Bacterial Vaccines

Dr Annaliesa Anderson, Vice President and CSO Bacterial Vaccines, Pfizer

Annaliesa Anderson PhD FAAM, has over 20 years of pharmaceutical research experience and is currently the Chief Scientific Officer for Bacterial Vaccines at Pfizer Inc. Her responsibilities include infectious disease vaccine R and D, surveillance and the assessment of the immunopathology of bacterial colonization and disease. Dr Andersons experience includes leadership roles for bacterial vaccine programs directed at the prevention of diseases due to Neisseria meningitidisStaphylococcus aureus and Clostridium difficile and Enterococcus sp. In this role, she has made substantial contributions to vaccine antigen discovery, preclinical proof of concept, clinical proof of concept and recently the licensure of the N. meningitidis serogroup B vaccine Trumenba®.


DC Co-conference Day 3 April 5 @ 09:40

Update on Group B streptococcal maternal immunization program

back to speakers